More of a little curiosity or some funny pastime while we are waiting for official newsflow reg enrollment or partnering. But it seems as if AI is on our side! ;-)
„Medical trials are as expensive and time consuming as they are vital. But AI has emerged that might well be able to predict results.
Given that, a positive trial result can put a rocket up a biotech company’s share price, while a negative one can send it into a tailspin.
The wonders of artificial intelligence mean that it is possible to predict a trial result with 90 per cent accuracy, according to life-sciences nanocap Opyl.
Opthea (ASX:OPT) has two Phase 3 trials for the eye condition wet aged-related macular degeneration, due to report mid next year. Combining the company’s therapy with different “standard of care” drugs, the trials are rated a solid 63.8 per cent and 52.32 per cent chance of success.“
=> click here <=
To be taken with a grain of smile…
- Forums
- ASX - By Stock
- Hang in there!!
More of a little curiosity or some funny pastime while we are...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $392.9M |
Open | High | Low | Value | Volume |
36.0¢ | 36.0¢ | 35.5¢ | $489.1K | 1.364M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 658599 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 149484 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 658599 | 0.355 |
37 | 496385 | 0.350 |
16 | 128921 | 0.345 |
9 | 214188 | 0.340 |
5 | 37677 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 150840 | 10 |
0.365 | 81389 | 10 |
0.370 | 263778 | 7 |
0.375 | 555302 | 9 |
0.380 | 189448 | 7 |
Last trade - 13.49pm 21/06/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online